Tg(Cd2-Tcra2E7,Cd4-Tcrb2E7)#Jbs
Transgene Detail
|
Symbol: |
Tg(Cd2-Tcra2E7,Cd4-Tcrb2E7)#Jbs |
Name: |
transgene insertion, Jeffrey Bluestone |
MGI ID: |
MGI:4453841 |
Synonyms: |
POT |
Transgene: |
Tg(Cd2-Tcra2E7,Cd4-Tcrb2E7)#Jbs Location: unknown
|
Alliance: |
Tg(Cd2-Tcra2E7,Cd4-Tcrb2E7)#Jbs page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Cd2-Tcra2E7,Cd4-Tcrb2E7)#Jbs expresses
2 genes
|
|
|
Mutation details: The full length coding sequence of recombined mouse Tcra from mouse hybridoma 2E7 uses Tcra-V9 and was placed under the control of the Cd2 promoter while the full length coding sequence of recombined mouse Tcrb from mouse hybridoma 2E7 uses Tcrb-V11 and was placed under the control of the Cd4 promoter. The two constructs were coinjected into single celled NOD embryos. CD4+ T cell hybridoma 2E7 contains T cell receptors specific for a peptide of Mpz (P0) containing the first 25 amino acids following the signal peptide.
(J:146797)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:146797 Louvet C, et al., A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy. J Exp Med. 2009 Mar 16;206(3):507-14 |
All: |
3 reference(s) |
|